- Home
- NCSM vs IMUX Comparison
NCSM vs IMUX Comparison
Compare NCSM & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCSM
- IMUX
- Stock Information
- Founded
- NCSM 2006
- IMUX 2016
- Country
- NCSM United States
- IMUX United States
- Employees
- NCSM N/A
- IMUX N/A
- Industry
- NCSM Oilfield Services/Equipment
- IMUX Biotechnology: Pharmaceutical Preparations
- Sector
- NCSM Energy
- IMUX Health Care
- Exchange
- NCSM Nasdaq
- IMUX Nasdaq
- Market Cap
- NCSM 79.3M
- IMUX 67.1M
- IPO Year
- NCSM 2017
- IMUX N/A
- Fundamental
- Price
- NCSM $32.32
- IMUX $0.72
- Analyst Decision
- NCSM
- IMUX Strong Buy
- Analyst Count
- NCSM 0
- IMUX 6
- Target Price
- NCSM N/A
- IMUX $11.60
- AVG Volume (30 Days)
- NCSM 6.9K
- IMUX 2.4M
- Earning Date
- NCSM 07-30-2025
- IMUX 08-07-2025
- Dividend Yield
- NCSM N/A
- IMUX N/A
- EPS Growth
- NCSM N/A
- IMUX N/A
- EPS
- NCSM 3.27
- IMUX N/A
- Revenue
- NCSM $168,704,000.00
- IMUX N/A
- Revenue This Year
- NCSM $7.17
- IMUX N/A
- Revenue Next Year
- NCSM $5.44
- IMUX N/A
- P/E Ratio
- NCSM $9.90
- IMUX N/A
- Revenue Growth
- NCSM 18.16
- IMUX N/A
- 52 Week Low
- NCSM $15.90
- IMUX $0.56
- 52 Week High
- NCSM $38.95
- IMUX $2.11
- Technical
- Relative Strength Index (RSI)
- NCSM 58.18
- IMUX 36.47
- Support Level
- NCSM $30.56
- IMUX $0.71
- Resistance Level
- NCSM $32.18
- IMUX $0.91
- Average True Range (ATR)
- NCSM 1.06
- IMUX 0.07
- MACD
- NCSM 0.24
- IMUX 0.00
- Stochastic Oscillator
- NCSM 97.35
- IMUX 29.20
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.